SCHEMBL5024092

SCHEMBL5024092

O=C(ONC1=NC(c2cccc(Br)c2)Cc2ccccc21)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 4/20 0.41
KDM1A O60341 1/20 0.35
HDAC4 P56524 1/20 0.34
MAPT P10636 3/20 0.33
NOS2 P35228 1/20 0.33
GAA P10253 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PDE5A O76074 1/20 0.33
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TSHR P16473 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ROCK2 O75116 1/20 0.31
ALDH1A1 P00352 2/20 0.31
LMNA P02545 1/20 0.31
HTT P42858 1/20 0.31
CCR6 P51684 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5026484 0.88 NOS3 (0.41) NOS3HDAC4MAPTNOS2
SCHEMBL5025594 0.82 LMNA (0.40) NOS3PDE5ATSHRALDH1A1LMNA
Trifluoroacetic Acid SCHEMBL5001990 0.78 NOS3 (0.60) NOS3KDM1AHDAC4NOS2
SCHEMBL5030034 0.72 HCAR3 (0.35) MAPTGAASMN1; SMN2MEN1KMT2A
SCHEMBL5026581 0.71 MAPT (0.34) MAPTGAASMN1; SMN2MEN1KMT2A
SCHEMBL5005082 0.71 NOS3 (0.71) NOS3KDM1ANOS2
Trifluoroacetic Acid SCHEMBL5095021 0.69 NOS2 (0.42) NOS3KDM1AHDAC4MAPTNOS2
SCHEMBL5026434 0.69 BACE1 (0.41) MAPTMEN1KMT2A
Trifluoroacetic Acid SCHEMBL5005119 0.65 NOS3 (0.61) NOS3NOS2
Trifluoroacetic Acid SCHEMBL5001834 0.65 NOS2 (0.60) NOS3KDM1AHDAC4NOS2PDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957462-A2 NOVEL 2-AMINO-HETEROCYCLES UDEFUL IN THE TREATMENT OF ABETA-RELATED PATHOLOGIES Astra Zeneca AB (SE) 2008-08-20 EP disclosed
WO-2007058583-A2 NOVEL 2-AMINO-HETEROCYCLES USEFUL IN THE TREATMENT OF ABETA-RELATED PATHOLOGIES ASTRAZENECA AB (SE) 2007-05-24 WO disclosed